Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease

2021 ◽  
Vol 51 (11) ◽  
pp. 1172-1173
Author(s):  
Nobuharu Tamaki ◽  
Masayuki Kurosaki ◽  
Mayu Higuchi ◽  
Namiki Izumi
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Risk Difference ◽  
Atherosclerotic Cardiovascular Disease ◽  
Metabolic Dysfunction ◽  
Nonalcoholic Fatty Liver ◽  
Atherosclerotic Cardiovascular Disease Risk

scholarly journals Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease

2017 ◽  
Vol 153 (5) ◽  
pp. 1260-1272.e3 ◽  
Author(s):  
Lisa B. VanWagner ◽  
Hongyan Ning ◽  
Norrina B. Allen ◽  
Veeral Ajmera ◽  
Cora E. Lewis ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Liver Disease ◽  
Alcohol Use ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Nonalcoholic Fatty Liver

Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients

2019 ◽  
Vol 65 (6) ◽  
pp. 1850-1860 ◽  
Author(s):  
Congxiang Shao ◽  
Junzhao Ye ◽  
Fuxi Li ◽  
Yansong Lin ◽  
Tingfeng Wu ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Obese Patients ◽  
Nonalcoholic Fatty Liver ◽  
Early Predictors

scholarly journals Nonalcoholic fatty liver disease and cardiovascular disease risk

2007 ◽  
Vol 7 (3) ◽  
pp. 181-187 ◽  
Author(s):  
Roger K. Schindhelm ◽  
Michaela Diamant ◽  
Robert J. Heine
Keyword(s):  
Cardiovascular Disease ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Nonalcoholic Fatty Liver

scholarly journals Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview

Biomolecules ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 473
Author(s):  
Helena Castañé ◽  
Gerard Baiges-Gaya ◽  
Anna Hernández-Aguilera ◽  
Elisabet Rodríguez-Tomàs ◽  
Salvador Fernández-Arroyo ◽  
...  
Keyword(s):  
Machine Learning ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Predictive Biomarkers ◽  
Metabolic Dysfunction ◽  
Complex Situation ◽  
Nonalcoholic Fatty Liver ◽  
General Overview ◽  
Diagnosis Accuracy

Hepatic biopsy is the gold standard for staging nonalcoholic fatty liver disease (NAFLD). Unfortunately, accessing the liver is invasive, requires a multidisciplinary team and is too expensive to be conducted on large segments of the population. NAFLD starts quietly and can progress until liver damage is irreversible. Given this complex situation, the search for noninvasive alternatives is clinically important. A hallmark of NAFLD progression is the dysregulation in lipid metabolism. In this context, recent advances in the area of machine learning have increased the interest in evaluating whether multi-omics data analysis performed on peripheral blood can enhance human interpretation. In the present review, we show how the use of machine learning can identify sets of lipids as predictive biomarkers of NAFLD progression. This approach could potentially help clinicians to improve the diagnosis accuracy and predict the future risk of the disease. While NAFLD has no effective treatment yet, the key to slowing the progression of the disease may lie in predictive robust biomarkers. Hence, to detect this disease as soon as possible, the use of computational science can help us to make a more accurate and reliable diagnosis. We aimed to provide a general overview for all readers interested in implementing these methods.

Risk difference of liver-related and cardiovascular events by liver fibrosis status in nonalcoholic fatty liver disease

2021 ◽  
Author(s):  
Nobuharu Tamaki ◽  
Mayu Higuchi ◽  
Masayuki Kurosaki ◽  
Rohit Loomba ◽  
Namiki Izumi ◽  
...  
Keyword(s):  
Liver Disease ◽  
Liver Fibrosis ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Cardiovascular Events ◽  
Risk Difference ◽  
Nonalcoholic Fatty Liver

Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease

2015 ◽  
Vol 27 (3) ◽  
pp. 298-304 ◽  
Author(s):  
Serkan Dogan ◽  
Mehmet Celikbilek ◽  
Yunus K. Yilmaz ◽  
Savas Sarikaya ◽  
Gokmen Zararsiz ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Liver Disease ◽  
Liver Fibrosis ◽  
Fatty Liver ◽  
Coronary Heart Disease Risk ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Nonalcoholic Fatty Liver ◽  
Heart Disease Risk
Sign in / Sign up

Export Citation Format

Share Document